BNP Paribas’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
BNP Paribas's OGN Position: Q2 2026 in Review
BNP Paribas sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 95 shares — an estimated $568 sold.
BNP Paribas first reported a position in OGN in Q1 2024 and held it in 9 quarters. The position peaked at $2.87K in Q1 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- BNP Paribas reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
- BNP Paribas sold 95 Organon & Co shares in Q2 2026, an estimated $568.
- BNP Paribas first reported a position in Organon & Co in Q1 2024 and held it in 9 quarters.
- BNP Paribas's Organon & Co position peaked at $2.87K in Q1 2024.
- 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.